companydata.dkcompanydata.dk

Rangers Pharmaceutical A/S: Financial statements 2024

CVR: 40381015

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

Rangers Pharmaceutical A/S (CVR 40381015) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -90,401 and a net result of DKK 1,641,287 compared with DKK 1,244,777 the year before. Equity in the 2024 report amounted to DKK -50,758,132.

Gross Profit
DKK -90,401
Profit/Loss
DKK 1,641,287
Equity
DKK -50,758,132
Total Assets
DKK 406,348

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024--90K1.6M-50.8M-
2023--232K1.2M-52.4M-
2022--1.1M-53.1M-53.6M-
2021--2.7M-2.7M-533K0
2020--302K-4.1M-829K1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

Rangers Pharmaceutical A/S: The 2023 annual report is outJun 26, 2024

Rangers Pharmaceutical A/S has published its annual report for 2023. Gross profit came to DKK -232,315, and the net result was DKK 1,244,777.

About Rangers Pharmaceutical A/S

Rangers Pharmaceutical A/S is a Danish company of the type Aktieselskab based in København K, founded in 2019. The company is in liquidation. The company is registered under the industry Dyrkning af krydderiplanter, aromaplanter og lægeplanter. The management consists of Niels Løber. The company is owned by Klokken Aarhus Inc.. The company has 1 employee (2019). In 2025, the company reported a gross profit of DKK -265,330 and a net result of DKK -265,257 compared with DKK 1,641,287 the year before. Equity in the 2025 report amounted to DKK 101,092.

Source: annual report 2025, Danish Business Authority

Other financial years